Coming Soon!


Disease Maps are a proxy for the cost changes experienced year-over-year and month-over-month. These analyses allow for targeting the therapeutic categories and medications responsible for the largest changes in drug spend.

Important client benefits are –

  • Which medications have experienced the greatest cost inflation?
  • Which therapeutic categories contain opportunities for reducing spend?

When coordinated with Physician Profiles opportunities for improving outcomes are --

  • Which prescribers and patients drive the drug spend?
  • What are the alternatives for reducing spend?
  • How do we know if spend has been reduced?

Contact Us

Information Sheet

To Learn More:
Phone:(888) 701-5438